Paudel, KAdhikari, SPant, P2026-04-242026-04-242016https://hdl.handle.net/20.500.14572/5950K Paudel Institute of Medicine, Maharajgunj Medical Campus, Tribhuvan University, Kathmandu, Nepal S Adhikari Institute of Medicine, Maharajgunj Medical Campus, Tribhuvan University, Kathmandu, Nepal P Pant Department of Internal Medicine, Institute of Medicine, Maharajgunj Medical Campus, Tribhuvan University, Kathmandu, NepalAbstract Allergic bronchopulmonary aspergillosis (ABPA) is a type II hypersensitivity lung disease induced by bronchial colonization of fungus, Aspergillus fumigatus that commonly occurs in patients with asthma or cystic fibrosis. We present a case of 65year-old Brahmin man, non smoker and non atopic who presented with increasing hemoptysis, initially suspected as pulmonary tuberculosis and later diagnosed as ABPA. He was managed with oral prednisolone 0.5mg/kg/day for 14 days followed by gradual tapering over the period of 6 weeks with remarkable response.en-USArticle